Repirinast
瑞吡司特
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameRepirinast
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1987/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesKaifeng Pharmaceutical (Group) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A